|
ABLIM1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.77500000253517E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.01709999977828E-07 |
| Normal-vs-Stage2 |
2.37069999999839E-05 |
| Normal-vs-Stage3 |
1.64170000005459E-06 |
| Normal-vs-Stage4 |
4.30270000000288E-05 |
| Stage1-vs-Stage2 |
7.813000E-01 |
| Stage1-vs-Stage3 |
2.925600E-01 |
| Stage1-vs-Stage4 |
4.451600E-01 |
| Stage2-vs-Stage3 |
5.487000E-01 |
| Stage2-vs-Stage4 |
5.391800E-01 |
| Stage3-vs-Stage4 |
9.424000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.18829999676373E-08 |
| Normal-vs-AfricanAmerican |
4.11469999961334E-07 |
| Normal-vs-Asian |
1.384590E-04 |
| Caucasian-vs-AfricanAmerican |
8.969200E-01 |
| Caucasian-vs-Asian |
2.927000E-01 |
| AfricanAmerican-vs-Asian |
1.951590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.54310009214953E-10 |
| Normal-vs-Female |
1.176130E-03 |
| Male-vs-Female |
8.862100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.07919999994921E-07 |
| Normal-vs-Extreme_Weight |
3.81679998717743E-09 |
| Normal-vs-Obese |
2.3387999999902E-05 |
| Normal-vs-Extreme_Obese |
1.168840E-04 |
| Normal_Weight-vs-Extreme_Weight |
9.102200E-01 |
| Normal_Weight-vs-Obese |
1.425400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.945000E-01 |
| Extreme_Weight-vs-Obese |
8.712300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.445600E-01 |
| Obese-vs-Extreme_Obese |
3.778200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.25199999999548E-05 |
| Normal-vs-Age(41-60Yrs) |
1.7979999999973E-05 |
| Normal-vs-Age(61-80Yrs) |
7.32280014403841E-10 |
| Normal-vs-Age(81-100Yrs) |
1.42989999996068E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.410000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.651400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.267800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.179580E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.139590E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.675200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.69479999981392E-07 |
| Normal-VS-Type2 PRCC |
6.52230003339582E-09 |
| Normal-VS-KIRP CIMP |
2.795500E-04 |
| Normal-VS-Unclassified PRCC |
2.255900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
7.688300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.022200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.865200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.934800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.678300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.454800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.29199984044703E-10 |
| Normal-vs-N1 |
5.53970000000126E-05 |
| Normal-vs-N2 |
4.435800E-03 |
| N0-vs-N1 |
1.839000E-01 |
| N0-vs-N2 |
8.714800E-01 |
| N1-vs-N2 |
6.719800E-01 |
|
|
